Search - tctmd.com

Displaying 141 - 160 of 505

Sort: Relevancy | Date

News Conference News CRT 2023

Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months

Yael L. Maxwell

February 28, 2023

News Opinion Editor's Corner ACC 2023

What’s Going to Be Hot at ACC/WCC 2023?

Shelley Wood

February 27, 2023

News Opinion CV Team Dispatch

February 2023 News Roundup

L.A. McKeown

February 15, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Daily News

BP Reduction With Renal Denervation Still Evident a Decade On

Michael O'Riordan

January 31, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Daily News

Medical Devices Cleared on Faulty Predicates More Likely to be Recalled

Michael O'Riordan

January 17, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2022

Shelley Wood

January 03, 2023

News Daily News

Top Endovascular News of 2022

L.A. McKeown

January 03, 2023

News Opinion Editor's Corner

The Biggest News of 2022: TCTMD’s Top 10

Shelley Wood

December 30, 2022

News Daily News

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Michael O'Riordan

December 20, 2022

News Daily News

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Michael O'Riordan

December 14, 2022

News Daily News

FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential

L.A. McKeown

December 06, 2022

News Features

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

L.A. McKeown

December 02, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2022

Caitlin E. Cox

December 01, 2022

News Daily News

Greater Carotid Plaque Burden in Asthmatic Patients: MESA

Michael O'Riordan

November 24, 2022

News Daily News

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Michael O'Riordan

November 18, 2022

News Conference News

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

L.A. McKeown

November 18, 2022

News Conference News AHA 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

Todd Neale

November 09, 2022

Advertisement

Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months

What’s Going to Be Hot at ACC/WCC 2023?

February 2023 News Roundup

Only Half of Revascularized PAD Patients Receive GDMT

BP Reduction With Renal Denervation Still Evident a Decade On

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

Medical Devices Cleared on Faulty Predicates More Likely to be Recalled

TCTMD’s Top 10 Most Popular Stories for December 2022

Top Endovascular News of 2022

The Biggest News of 2022: TCTMD’s Top 10

Reduction in BP Drives Treatment Preference for Hypertensive Patients

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

TCTMD’s Top 10 Most Popular Stories for November 2022

Greater Carotid Plaque Burden in Asthmatic Patients: MESA

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content